Healthcare provider profile · identity verified

Mark Hroncich, MD

Internal Medicine · BERWYN, IL · NPI 1265465108

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	564	176
Amlodipine Besylate	Amlodipine Besylate	283	85
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	283	40
Lisinopril	Lisinopril	242	68
Levothyroxine Sodium	Levothyroxine Sodium	225	63
Gabapentin	Gabapentin	224	65
Furosemide	Furosemide	212	65
Tamsulosin Hcl	Tamsulosin Hcl	203	65
Losartan Potassium	Losartan Potassium	199	59
Metformin Hcl	Metformin Hcl	198	58
Metoprolol Succinate	Metoprolol Succinate	195	63
Alprazolam	Alprazolam	189	32
Simvastatin	Simvastatin	181	50
Pantoprazole Sodium	Pantoprazole Sodium	162	49
Metformin Hcl Er	Metformin Hcl	149	48
Rosuvastatin Calcium	Rosuvastatin Calcium	143	45
Tramadol Hcl	Tramadol Hcl	135	50
Hydrochlorothiazide	Hydrochlorothiazide	132	38
Eliquis	Apixaban	127	32
Omeprazole	Omeprazole	123	35
Albuterol Sulfate Hfa	Albuterol Sulfate	109	38
Trazodone Hcl	Trazodone Hcl	99	34
Glipizide	Glipizide	97	28
Meloxicam	Meloxicam	91	32
Carvedilol	Carvedilol	85	21
Duloxetine Hcl	Duloxetine Hcl	81	22
Azithromycin	Azithromycin	77	52
Alendronate Sodium	Alendronate Sodium	76	28
Glipizide Er	Glipizide	76	17
Escitalopram Oxalate	Escitalopram Oxalate	71	21
Prednisone	Prednisone	70	45
Allopurinol	Allopurinol	68	23
Famotidine	Famotidine	68	27
Lorazepam	Lorazepam	67	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	65	21
Montelukast Sodium	Montelukast Sodium	64	13
Finasteride	Finasteride	59	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	27
Fluticasone Propionate	Fluticasone Propionate	58	28
Januvia	Sitagliptin Phosphate	58	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	57	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	19
Ketoconazole	Ketoconazole	56	19
Pravastatin Sodium	Pravastatin Sodium	55	17
Ozempic	Semaglutide	54	14
Potassium Chloride	Potassium Chloride	53	14
Celecoxib	Celecoxib	50	13
Ezetimibe	Ezetimibe	49	16
Vitamin D2	Ergocalciferol (Vitamin D2)	49	14
Nabumetone	Nabumetone	48	15
Enalapril Maleate	Enalapril Maleate	47	11
Esomeprazole Magnesium	Esomeprazole Magnesium	46	suppressed
Sertraline Hcl	Sertraline Hcl	46	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	34
Clonazepam	Clonazepam	39	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	13
Meclizine Hcl	Meclizine Hcl	35	16
Memantine Hcl	Memantine Hcl	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	13
Mometasone Furoate	Mometasone Furoate	32	22
Pregabalin	Pregabalin	31	13
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Nystatin	Nystatin	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Cephalexin	Cephalexin	27	24
Donepezil Hcl	Donepezil Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	24
Diclofenac Sodium	Diclofenac Sodium	26	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Naproxen	Naproxen	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	11
Dutasteride	Dutasteride	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	14
Torsemide	Torsemide	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Valsartan	Valsartan	20	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Atenolol	Atenolol	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	11
Entresto	Sacubitril/Valsartan	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Fluconazole	Fluconazole	15	12
Mupirocin	Mupirocin	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Risperidone	Risperidone	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	11
Restasis Multidose	Cyclosporine	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Verapamil Hcl	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error